Empty Capsules Market by Product {Gelatin Capsules (Hard Gelatin Capsules (HGCs) & Soft Gelatin Capsules (SGCs)) and Non-gelatin Capsules}, Raw Material (Pig Meat, Bovine Meat, Bones, HPMC, and Other Raw Materials), Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Cardiac Therapy Drugs, and Other Applications), and End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2017-2025
The global empty capsules market was valued at $1,841.5 million in 2017 and is expected to reach $3,707.5 million by 2025, registering a CAGR of 9.1% from 2018 to 2025. Capsules are defined as hard or soft containers that can enclose medicines in a particular dosage form. The popularity of capsule drug delivery form has increased in the recent years because capsules act as relatively stable shells protecting the active pharmaceutical ingredients (APIs) and enable targeted drug delivery.
The demand for both gelatin and non-gelatin capsules for oral consumption has increased over the years. Non-gelatin capsules majorly comprise hydroxypropyl methylcellulose (HPMC), which acts as an ideal substitute for gelatin capsules. The consumption of both gelatin and HPMC capsules are significantly high across the globe because they eliminate the need for fillers. In 2014, about 10–15% of the supplements and medications launched in the U.S. were in the form of capsules. This is a gigantic increase from the previous figure of 5% in 2007. Over a span of time, gelatin capsules have become an ideal the choice of capsules among pharmaceutical manufacturers and nutraceutical manufacturers. Gelatin dissolves easily, and is therefore an ideal option for encapsulation of medicines as well as supplements. In addition, gelatin is highly compatible with other ingredients used in drug formulations and contains proteins that can be easily digested in the gastrointestinal tract.
Factors, such as rise in the geriatric population who are more susceptible to acute and chronic ailments, increase in demand for capsules over other drug delivery forms, and high inclination of patients toward non-invasive treatments for cardiac disorders propel the market growth. However, rise in the prices of gelatin as a raw material and ethical issues associated with its procurement are expected to hamper the market growth. Innovative capsule drug delivery technologies introduced in the market are anticipated to open new avenues in the global empty capsules market in the near future.
The global empty capsules market is segmented based on product, raw material, therapeutic application, end user, and region. Based on product, the market is bifurcated into gelatin and non-gelatin capsules. The gelatin capsules are further divided into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). According to raw material, the market is divided into pig meat, bovine meat, bones, HPMC, and other raw materials. On the basis of therapeutic application, the market is classified into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and other applications. The end users of the industry are broadly categorized into pharmaceutical manufacturers, nutraceutical manufacturers, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, CIS (Commonwealth of Independent States), and MENA (Middle East and North Africa).
KEY BENEFITS FOR STAKEHOLDERS
By Product
The demand for both gelatin and non-gelatin capsules for oral consumption has increased over the years. Non-gelatin capsules majorly comprise hydroxypropyl methylcellulose (HPMC), which acts as an ideal substitute for gelatin capsules. The consumption of both gelatin and HPMC capsules are significantly high across the globe because they eliminate the need for fillers. In 2014, about 10–15% of the supplements and medications launched in the U.S. were in the form of capsules. This is a gigantic increase from the previous figure of 5% in 2007. Over a span of time, gelatin capsules have become an ideal the choice of capsules among pharmaceutical manufacturers and nutraceutical manufacturers. Gelatin dissolves easily, and is therefore an ideal option for encapsulation of medicines as well as supplements. In addition, gelatin is highly compatible with other ingredients used in drug formulations and contains proteins that can be easily digested in the gastrointestinal tract.
Factors, such as rise in the geriatric population who are more susceptible to acute and chronic ailments, increase in demand for capsules over other drug delivery forms, and high inclination of patients toward non-invasive treatments for cardiac disorders propel the market growth. However, rise in the prices of gelatin as a raw material and ethical issues associated with its procurement are expected to hamper the market growth. Innovative capsule drug delivery technologies introduced in the market are anticipated to open new avenues in the global empty capsules market in the near future.
The global empty capsules market is segmented based on product, raw material, therapeutic application, end user, and region. Based on product, the market is bifurcated into gelatin and non-gelatin capsules. The gelatin capsules are further divided into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). According to raw material, the market is divided into pig meat, bovine meat, bones, HPMC, and other raw materials. On the basis of therapeutic application, the market is classified into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and other applications. The end users of the industry are broadly categorized into pharmaceutical manufacturers, nutraceutical manufacturers, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, CIS (Commonwealth of Independent States), and MENA (Middle East and North Africa).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global empty capsules market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A Comprehensive analysis of the factors that drive and restrict the market growth is included in the study.
- A Comprehensive quantitative analysis of the industry for the period of 2016-2023 is provided to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry is provided to understand the trends in the empty capsules industry, worldwide.
- The profiles of key players along with their strategies are provided to understand the competitive outlook of the industry.
By Product
- Gelatin Capsule
- Hard Gelatin Capsule (HGC)
- Soft Gelatin Capsule (SGC)
- Non-gelatin Capsule
- Pig Meat
- Bovine Meat
- Bone
- HPMC
- Other Raw Materials
- Antibiotic & Antibacterial Drug
- Vitamin & Dietary Supplement
- Antacids & Anti-flatulent Preparation
- Cardiac Therapy Drug
- Other Applications
- Pharmaceutical Manufacturer
- Nutraceutical Manufacturer
- Other End Users
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- CIS
- Russia
- Kazakhstan
- Azerbaijan
- Rest of CIS
- MENA
- Saudi Arabia
- Iran
- UAE
- Algeria
- Egypt
- Rest of MENA
- ACG Worldwide
- Bright Pharma Caps, Inc.
- CapsCanada Corporation
- Lonza Group Ltd. (Capsugel)
- Medi-Caps Ltd.
- Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
- Roxlor LLC.
- Snail Pharma Industry Co. Ltd.
- Suheung Co., Ltd.
- Sunil Healthcare Ltd.
- Patheon Ltd.
- Nectar Lifesciences Ltd.
- JC Biological Technologies
- Natural Capsules Ltd.
- Zhejiang Huili Capsules Co., Ltd.
- Healthcaps India Limited
- HTC Group Limited
- Nanjing Saturn Pharmaceutical Technology Co., Ltd.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porters Five Forces analysis
3.3. Key findings
3.3.1. Top investment pockets, 2017
3.3.2. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in popularity of capsules over other drug delivery forms
3.4.1.2. Increase in strategic collaboration between empty capsule suppliers and gelatin manufacturers
3.4.1.3. Rise in advancements in the development of capsules
3.4.2. Restraints
3.4.2.1. Ethical concerns along with the price fluctuations regarding gelatin material
3.4.2.2. Stringent regulations in pharmaceutical industry
3.4.3. Opportunity
3.4.3.1. Developing economies offer lucrative opportunities
CHAPTER 4: EMPTY CAPSULES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Gelatin Capsules
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Hard Gelatin Capsules (HGCs)
4.2.4.1. Market Size and Forecast
4.2.5. Soft Gelatin
4.2.5.1. Market Size and Forecast
4.3. Non-Gelatin
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: EMPTY CAPSULES MARKET, BY RAW MATERIAL
5.1. Overview.
5.1.1. Market size and forecast
5.2. Pig Meat
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Bovine Meat
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Bone
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. HPMC
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other Raw Materials
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
6.1. Overview.
6.1.1. Market size and forecast
6.2. Antibiotic & Antibacterial Drugs
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Vitamin & Dietary Supplements
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Antacids & Anti-flatulent Preparations
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Cardiac Therapy Drugs
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Other Applications
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
CHAPTER 7: EMPTY CAPSULES MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceuticals Manufacturers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Nutraceutical Manufacturers
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Other End Users
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
CHAPTER 8: EMPTY CAPSULES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. market size and forecast, by product
8.2.2.2. U.S. market size and forecast, by raw material
8.2.2.3. U.S. market size and forecast, by therapeutic application
8.2.2.4. U.S. market size and forecast, by end user
8.2.2.5. Canada market size and forecast, by product
8.2.2.6. Canada market size and forecast, by raw material
8.2.2.7. Canada market size and forecast, by therapeutic application
8.2.2.8. Canada market size and forecast, by end user
8.2.2.9. Mexico market size and forecast, by product
8.2.2.10. Mexico market size and forecast, by raw material
8.2.2.11. Mexico market size and forecast, by therapeutic application
8.2.2.12. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by raw material
8.2.5. North America market size and forecast, by therapeutic application
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany market size and forecast, by product
8.3.2.2. Germany market size and forecast, by raw material
8.3.2.3. Germany market size and forecast, by therapeutic application
8.3.2.4. Germany market size and forecast, by end user
8.3.2.5. UK market size and forecast, by product
8.3.2.6. UK market size and forecast, by raw material
8.3.2.7. UK market size and forecast, by therapeutic application
8.3.2.8. UK market size and forecast, by end user
8.3.2.9. France market size and forecast, by product
8.3.2.10. France market size and forecast, by raw material
8.3.2.11. France market size and forecast, by therapeutic application
8.3.2.12. France market size and forecast, by end user
8.3.2.13. Rest of Europe market size and forecast, by product
8.3.2.14. Rest of Europe market size and forecast, by raw material
8.3.2.15. Rest of Europe market size and forecast, by therapeutic application
8.3.2.16. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by raw material
8.3.5. Europe market size and forecast, by therapeutic application
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan market size and forecast, by product
8.4.2.2. Japan market size and forecast, by raw material
8.4.2.3. Japan market size and forecast, by therapeutic application
8.4.2.4. Japan market size and forecast, by end user
8.4.2.5. China market size and forecast, by product
8.4.2.6. China market size and forecast, by raw material
8.4.2.7. China market size and forecast, by therapeutic application
8.4.2.8. China market size and forecast, by end user
8.4.2.9. India market size and forecast, by product
8.4.2.10. India market size and forecast, by raw material
8.4.2.11. India market size and forecast, by therapeutic application
8.4.2.12. India market size and forecast, by end user
8.4.2.13. Rest of Asia-Pacific market size and forecast, by product
8.4.2.14. Rest of Asia-Pacific market size and forecast, by raw material
8.4.2.15. Rest of Asia-Pacific market size and forecast, by therapeutic application
8.4.2.16. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by raw material
8.4.5. Asia-Pacific market size and forecast, by therapeutic application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. CIS
8.5.1. Key trends and opportunities
8.5.2. CIS market size and forecast, by country
8.5.2.1. Russia market size and forecast, by product
8.5.2.2. Russia market size and forecast, by raw material
8.5.2.3. Russia market size and forecast, by therapeutic application
8.5.2.4. Russia market size and forecast, by end user
8.5.2.5. Kazakhstan market size and forecast, by product
8.5.2.6. Kazakhstan market size and forecast, by raw material
8.5.2.7. Kazakhstan market size and forecast, by therapeutic application
8.5.2.8. Kazakhstan market size and forecast, by end user
8.5.2.9. Azerbaijan market size and forecast, by product
8.5.2.10. Azerbaijan market size and forecast, by raw material
8.5.2.11. Azerbaijan market size and forecast, by therapeutic application
8.5.2.12. Azerbaijan market size and forecast, by end user
8.5.2.13. Rest of CIS market size and forecast, by product
8.5.2.14. Rest of CIS market size and forecast, by raw material
8.5.2.15. Rest of CIS market size and forecast, by therapeutic application
8.5.2.16. Rest of CIS market size and forecast, by end user
8.5.3. CIS market size and forecast, by product
8.5.4. CIS market size and forecast, by raw material
8.5.5. CIS market size and forecast, by therapeutic application
8.5.6. CIS market size and forecast, by end user
8.6. MENA
8.6.1. Key trends and opportunities
8.6.2. MENA market size and forecast, by country
8.6.2.1. Saudi Arabia market size and forecast, by product
8.6.2.2. Saudi Arabia market size and forecast, by raw material
8.6.2.3. Saudi Arabia market size and forecast, by therapeutic application
8.6.2.4. Saudi Arabia market size and forecast, by end user
8.6.2.5. Iran market size and forecast, by product
8.6.2.6. Iran market size and forecast, by raw material
8.6.2.7. Iran market size and forecast, by therapeutic application
8.6.2.8. Iran market size and forecast, by end user
8.6.2.9. UAE market size and forecast, by product
8.6.2.10. UAE market size and forecast, by raw material
8.6.2.11. UAE market size and forecast, by therapeutic application
8.6.2.12. UAE market size and forecast, by end user
8.6.2.13. Algeria market size and forecast, by product
8.6.2.14. Algeria market size and forecast, by raw material
8.6.2.15. Algeria market size and forecast, by therapeutic application
8.6.2.16. Algeria market size and forecast, by end user
8.6.2.17. Egypt market size and forecast, by product
8.6.2.18. Egypt market size and forecast, by raw material
8.6.2.19. Egypt market size and forecast, by therapeutic application
8.6.2.20. Egypt market size and forecast, by end user
8.6.2.21. Rest of MENA market size and forecast, by product
8.6.2.22. Rest of MENA market size and forecast, by raw material
8.6.2.23. Rest of MENA market size and forecast, by therapeutic application
8.6.2.24. Rest of MENA market size and forecast, by end user
8.6.3. MENA market size and forecast, by product
8.6.4. MENA market size and forecast, by raw material
8.6.5. MENA market size and forecast, by therapeutic application
8.6.6. MENA market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. ACG Worldwide
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. Bright Pharma Caps Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio
9.2.4. Key strategic moves and developments
9.3. CapsCanada Corporation
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio
9.3.4. Key strategic moves and developments
9.4. Lonza Group Ltd. (Capsugel)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Medi-Caps Ltd.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Roxlor LLC
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Snail Pharma Industry Co. Ltd.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.9. Suheung Co., Ltd.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio
9.10. Sunil Healthcare Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porters Five Forces analysis
3.3. Key findings
3.3.1. Top investment pockets, 2017
3.3.2. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in popularity of capsules over other drug delivery forms
3.4.1.2. Increase in strategic collaboration between empty capsule suppliers and gelatin manufacturers
3.4.1.3. Rise in advancements in the development of capsules
3.4.2. Restraints
3.4.2.1. Ethical concerns along with the price fluctuations regarding gelatin material
3.4.2.2. Stringent regulations in pharmaceutical industry
3.4.3. Opportunity
3.4.3.1. Developing economies offer lucrative opportunities
CHAPTER 4: EMPTY CAPSULES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Gelatin Capsules
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Hard Gelatin Capsules (HGCs)
4.2.4.1. Market Size and Forecast
4.2.5. Soft Gelatin
4.2.5.1. Market Size and Forecast
4.3. Non-Gelatin
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
CHAPTER 5: EMPTY CAPSULES MARKET, BY RAW MATERIAL
5.1. Overview.
5.1.1. Market size and forecast
5.2. Pig Meat
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Bovine Meat
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Bone
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. HPMC
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other Raw Materials
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
6.1. Overview.
6.1.1. Market size and forecast
6.2. Antibiotic & Antibacterial Drugs
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Vitamin & Dietary Supplements
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Antacids & Anti-flatulent Preparations
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Cardiac Therapy Drugs
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Other Applications
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
CHAPTER 7: EMPTY CAPSULES MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceuticals Manufacturers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Nutraceutical Manufacturers
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Other End Users
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
CHAPTER 8: EMPTY CAPSULES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. market size and forecast, by product
8.2.2.2. U.S. market size and forecast, by raw material
8.2.2.3. U.S. market size and forecast, by therapeutic application
8.2.2.4. U.S. market size and forecast, by end user
8.2.2.5. Canada market size and forecast, by product
8.2.2.6. Canada market size and forecast, by raw material
8.2.2.7. Canada market size and forecast, by therapeutic application
8.2.2.8. Canada market size and forecast, by end user
8.2.2.9. Mexico market size and forecast, by product
8.2.2.10. Mexico market size and forecast, by raw material
8.2.2.11. Mexico market size and forecast, by therapeutic application
8.2.2.12. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by raw material
8.2.5. North America market size and forecast, by therapeutic application
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany market size and forecast, by product
8.3.2.2. Germany market size and forecast, by raw material
8.3.2.3. Germany market size and forecast, by therapeutic application
8.3.2.4. Germany market size and forecast, by end user
8.3.2.5. UK market size and forecast, by product
8.3.2.6. UK market size and forecast, by raw material
8.3.2.7. UK market size and forecast, by therapeutic application
8.3.2.8. UK market size and forecast, by end user
8.3.2.9. France market size and forecast, by product
8.3.2.10. France market size and forecast, by raw material
8.3.2.11. France market size and forecast, by therapeutic application
8.3.2.12. France market size and forecast, by end user
8.3.2.13. Rest of Europe market size and forecast, by product
8.3.2.14. Rest of Europe market size and forecast, by raw material
8.3.2.15. Rest of Europe market size and forecast, by therapeutic application
8.3.2.16. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by raw material
8.3.5. Europe market size and forecast, by therapeutic application
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan market size and forecast, by product
8.4.2.2. Japan market size and forecast, by raw material
8.4.2.3. Japan market size and forecast, by therapeutic application
8.4.2.4. Japan market size and forecast, by end user
8.4.2.5. China market size and forecast, by product
8.4.2.6. China market size and forecast, by raw material
8.4.2.7. China market size and forecast, by therapeutic application
8.4.2.8. China market size and forecast, by end user
8.4.2.9. India market size and forecast, by product
8.4.2.10. India market size and forecast, by raw material
8.4.2.11. India market size and forecast, by therapeutic application
8.4.2.12. India market size and forecast, by end user
8.4.2.13. Rest of Asia-Pacific market size and forecast, by product
8.4.2.14. Rest of Asia-Pacific market size and forecast, by raw material
8.4.2.15. Rest of Asia-Pacific market size and forecast, by therapeutic application
8.4.2.16. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by raw material
8.4.5. Asia-Pacific market size and forecast, by therapeutic application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. CIS
8.5.1. Key trends and opportunities
8.5.2. CIS market size and forecast, by country
8.5.2.1. Russia market size and forecast, by product
8.5.2.2. Russia market size and forecast, by raw material
8.5.2.3. Russia market size and forecast, by therapeutic application
8.5.2.4. Russia market size and forecast, by end user
8.5.2.5. Kazakhstan market size and forecast, by product
8.5.2.6. Kazakhstan market size and forecast, by raw material
8.5.2.7. Kazakhstan market size and forecast, by therapeutic application
8.5.2.8. Kazakhstan market size and forecast, by end user
8.5.2.9. Azerbaijan market size and forecast, by product
8.5.2.10. Azerbaijan market size and forecast, by raw material
8.5.2.11. Azerbaijan market size and forecast, by therapeutic application
8.5.2.12. Azerbaijan market size and forecast, by end user
8.5.2.13. Rest of CIS market size and forecast, by product
8.5.2.14. Rest of CIS market size and forecast, by raw material
8.5.2.15. Rest of CIS market size and forecast, by therapeutic application
8.5.2.16. Rest of CIS market size and forecast, by end user
8.5.3. CIS market size and forecast, by product
8.5.4. CIS market size and forecast, by raw material
8.5.5. CIS market size and forecast, by therapeutic application
8.5.6. CIS market size and forecast, by end user
8.6. MENA
8.6.1. Key trends and opportunities
8.6.2. MENA market size and forecast, by country
8.6.2.1. Saudi Arabia market size and forecast, by product
8.6.2.2. Saudi Arabia market size and forecast, by raw material
8.6.2.3. Saudi Arabia market size and forecast, by therapeutic application
8.6.2.4. Saudi Arabia market size and forecast, by end user
8.6.2.5. Iran market size and forecast, by product
8.6.2.6. Iran market size and forecast, by raw material
8.6.2.7. Iran market size and forecast, by therapeutic application
8.6.2.8. Iran market size and forecast, by end user
8.6.2.9. UAE market size and forecast, by product
8.6.2.10. UAE market size and forecast, by raw material
8.6.2.11. UAE market size and forecast, by therapeutic application
8.6.2.12. UAE market size and forecast, by end user
8.6.2.13. Algeria market size and forecast, by product
8.6.2.14. Algeria market size and forecast, by raw material
8.6.2.15. Algeria market size and forecast, by therapeutic application
8.6.2.16. Algeria market size and forecast, by end user
8.6.2.17. Egypt market size and forecast, by product
8.6.2.18. Egypt market size and forecast, by raw material
8.6.2.19. Egypt market size and forecast, by therapeutic application
8.6.2.20. Egypt market size and forecast, by end user
8.6.2.21. Rest of MENA market size and forecast, by product
8.6.2.22. Rest of MENA market size and forecast, by raw material
8.6.2.23. Rest of MENA market size and forecast, by therapeutic application
8.6.2.24. Rest of MENA market size and forecast, by end user
8.6.3. MENA market size and forecast, by product
8.6.4. MENA market size and forecast, by raw material
8.6.5. MENA market size and forecast, by therapeutic application
8.6.6. MENA market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. ACG Worldwide
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. Bright Pharma Caps Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio
9.2.4. Key strategic moves and developments
9.3. CapsCanada Corporation
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio
9.3.4. Key strategic moves and developments
9.4. Lonza Group Ltd. (Capsugel)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Medi-Caps Ltd.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Roxlor LLC
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Snail Pharma Industry Co. Ltd.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.9. Suheung Co., Ltd.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio
9.10. Sunil Healthcare Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 02. GELATIN EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03. NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. GLOBAL EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 05. PIG MEAT EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. BOVINE MEAT EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. BONE EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. HPMC EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 09. OTHER RAW MATERIALS EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. GLOBAL EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 11. EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2017-2025 ($MILLION)
TABLE 12. EMPTY CAPSULES MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY REGION, 2017-2025 ($MILLION)
TABLE 13. EMPTY CAPSULES MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 14. EMPTY CAPSULES MARKET FOR CARDIAC THERAPY DRUGS, BY REGION, 2017-2025 ($MILLION)
TABLE 15. EMPTY CAPSULES MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 16. GLOBAL EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 17. EMPTY CAPSULES MARKET FOR PHARMACEUTICALS, BY REGION, 2017-2025 ($MILLION)
TABLE 18. EMPTY CAPSULES MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY REGION, 2017-2025 ($MILLION)
TABLE 19. EMPTY CAPSULES MARKET FOR OTHER END USERS, BY REGION, 2017-2025 ($MILLION)
TABLE 20. EMPTY CAPSULESMARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 21. NORTH AMERICA EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 22. U.S. EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 23. U.S. EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 24. U.S. EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 25. U.S. EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. CANADA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 27. CANADA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 28. CANADA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 29. CANADA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 30. MEXICO EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 31. MEXICO EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 32. MEXICO EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 33. MEXICO EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 34. NORTH AMERICA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 35. NORTH AMERICA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 36. NORTH AMERICA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 37. NORTH AMERICA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 38. EUROPE EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 39. GERMANY EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 40. GERMANY EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 41. GERMANY EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 42. GERMANY EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 43. UK EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 44. UK EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 45. UK EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 46. UK EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 47. FRANCE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 48. FRANCE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 49. FRANCE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 50. FRANCE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 51. REST OF EUROPE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 52. REST OF EUROPE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 53. REST OF EUROPE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 54. REST OF EUROPE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 55. EUROPE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 56. EUROPE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 57. EUROPE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 58. EUROPE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 59. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 60. JAPAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 61. JAPAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 62. JAPAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 63. JAPAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 64. CHINA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 65. CHINA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 66. CHINA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 67. CHINA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 68. INDIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 69. INDIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 70. INDIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 71. INDIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 76. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 77. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 78. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 79. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. CIS EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 81. RUSSIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 82. RUSSIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 83. RUSSIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 84. RUSSIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 85. KAZAKHSTAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 86. KAZAKHSTAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 87. KAZAKHSTAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 88. KAZAKHSTAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 89. AZERBAIJAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 90. AZERBAIJAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 91. AZERBAIJAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 92. AZERBAIJAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 93. REST OF CIS EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 94. REST OF CIS EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 95. REST OF CIS EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 96. REST OF CIS EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 97. CIS EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 98. CIS EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 99. CIS EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 100. CIS EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 101. MENA EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 102. SAUDI ARABIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 103. SAUDI ARABIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 104. SAUDI ARABIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 105. SAUDI ARABIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 106. IRAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 107. IRAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 108. IRAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 109. IRAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 110. UAE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 111. UAE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 112. UAE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 113. UAE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 114. ALGERIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 115. ALGERIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 116. ALGERIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 117. ALGERIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 118. EGYPT EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 119. EGYPT EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 120. EGYPT EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 121. EGYPT EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 122. REST OF MENA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 123. REST OF MENA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 124. REST OF MENA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 125. REST OF MENA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 126. MENA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 127. MENA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 128. MENA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 129. MENA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 130. ACG: COMPANY SNAPSHOT
TABLE 131. ACG: PRODUCT SEGMENTS
TABLE 132. ACG: PRODUCT PORTFOLIO
TABLE 133. BRIGHT PHARMACAPS: COMPANY SNAPSHOT
TABLE 134. BRIGHT PHARMACAPS: PRODUCT PORTFOLIO
TABLE 135. CAPSCANADA: COMPANY SNAPSHOT
TABLE 136. CAPSCANADA: PRODUCT PORTFOLIO
TABLE 137. LONZA GROUP: COMPANY SNAPSHOT
TABLE 138. LONZA GROUP: OPERATING SEGMENTS
TABLE 139. LONZA GROUP: PRODUCT PORTFOLIO
TABLE 140. MEDI-CAPS: COMPANY SNAPSHOT
TABLE 141. MEDI-CAPS: PRODUCT PORTFOLIO
TABLE 142. MITSUBISHI CHEMICAL: COMPANY SNAPSHOT
TABLE 143. MITSUBISHI CHEMICAL: OPERATING SEGMENTS
TABLE 144. MITSUBISHI CHEMICAL: PRODUCT PORTFOLIO
TABLE 145. ROXLOR: COMPANY SNAPSHOT
TABLE 146. ROXLOR: PRODUCT SEGMENTS
TABLE 147. ROXLOR: PRODUCT PORTFOLIO
TABLE 148. SNAIL PHARMA INDUSTRY: COMPANY SNAPSHOT
TABLE 149. SNAIL PHARMA INDUSTRY: PRODUCT SEGMENTS
TABLE 150. SNAIL PHARMA INDUSTRY: PRODUCT PORTFOLIO
TABLE 151. SUHEUNG CAPSULE: COMPANY SNAPSHOT
TABLE 152. SUHEUNG CAPSULE: PRODUCT PORTFOLIO
TABLE 153. SUNIL HEALTHCARE: COMPANY SNAPSHOT
TABLE 154. SUNIL HEALTHCARE: OPERATING SEGMENTS
TABLE 155. SUNIL HEALTHCARE: PRODUCT PORTFOLIO
TABLE 01. GLOBAL EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 02. GELATIN EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03. NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. GLOBAL EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 05. PIG MEAT EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. BOVINE MEAT EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. BONE EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. HPMC EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 09. OTHER RAW MATERIALS EMPTY CAPSULES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. GLOBAL EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 11. EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2017-2025 ($MILLION)
TABLE 12. EMPTY CAPSULES MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY REGION, 2017-2025 ($MILLION)
TABLE 13. EMPTY CAPSULES MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 14. EMPTY CAPSULES MARKET FOR CARDIAC THERAPY DRUGS, BY REGION, 2017-2025 ($MILLION)
TABLE 15. EMPTY CAPSULES MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 16. GLOBAL EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 17. EMPTY CAPSULES MARKET FOR PHARMACEUTICALS, BY REGION, 2017-2025 ($MILLION)
TABLE 18. EMPTY CAPSULES MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY REGION, 2017-2025 ($MILLION)
TABLE 19. EMPTY CAPSULES MARKET FOR OTHER END USERS, BY REGION, 2017-2025 ($MILLION)
TABLE 20. EMPTY CAPSULESMARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 21. NORTH AMERICA EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 22. U.S. EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 23. U.S. EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 24. U.S. EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 25. U.S. EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. CANADA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 27. CANADA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 28. CANADA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 29. CANADA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 30. MEXICO EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 31. MEXICO EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 32. MEXICO EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 33. MEXICO EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 34. NORTH AMERICA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 35. NORTH AMERICA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 36. NORTH AMERICA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 37. NORTH AMERICA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 38. EUROPE EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 39. GERMANY EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 40. GERMANY EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 41. GERMANY EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 42. GERMANY EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 43. UK EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 44. UK EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 45. UK EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 46. UK EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 47. FRANCE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 48. FRANCE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 49. FRANCE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 50. FRANCE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 51. REST OF EUROPE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 52. REST OF EUROPE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 53. REST OF EUROPE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 54. REST OF EUROPE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 55. EUROPE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 56. EUROPE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 57. EUROPE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 58. EUROPE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 59. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 60. JAPAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 61. JAPAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 62. JAPAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 63. JAPAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 64. CHINA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 65. CHINA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 66. CHINA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 67. CHINA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 68. INDIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 69. INDIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 70. INDIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 71. INDIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 76. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 77. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 78. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 79. ASIA-PACIFIC EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. CIS EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 81. RUSSIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 82. RUSSIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 83. RUSSIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 84. RUSSIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 85. KAZAKHSTAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 86. KAZAKHSTAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 87. KAZAKHSTAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 88. KAZAKHSTAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 89. AZERBAIJAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 90. AZERBAIJAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 91. AZERBAIJAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 92. AZERBAIJAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 93. REST OF CIS EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 94. REST OF CIS EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 95. REST OF CIS EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 96. REST OF CIS EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 97. CIS EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 98. CIS EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 99. CIS EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 100. CIS EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 101. MENA EMPTY CAPSULES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 102. SAUDI ARABIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 103. SAUDI ARABIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 104. SAUDI ARABIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 105. SAUDI ARABIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 106. IRAN EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 107. IRAN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 108. IRAN EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 109. IRAN EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 110. UAE EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 111. UAE EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 112. UAE EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 113. UAE EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 114. ALGERIA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 115. ALGERIA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 116. ALGERIA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 117. ALGERIA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 118. EGYPT EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 119. EGYPT EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 120. EGYPT EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 121. EGYPT EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 122. REST OF MENA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 123. REST OF MENA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 124. REST OF MENA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 125. REST OF MENA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 126. MENA EMPTY CAPSULES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 127. MENA EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2017-2025 ($MILLION)
TABLE 128. MENA EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2017-2025 ($MILLION)
TABLE 129. MENA EMPTY CAPSULES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 130. ACG: COMPANY SNAPSHOT
TABLE 131. ACG: PRODUCT SEGMENTS
TABLE 132. ACG: PRODUCT PORTFOLIO
TABLE 133. BRIGHT PHARMACAPS: COMPANY SNAPSHOT
TABLE 134. BRIGHT PHARMACAPS: PRODUCT PORTFOLIO
TABLE 135. CAPSCANADA: COMPANY SNAPSHOT
TABLE 136. CAPSCANADA: PRODUCT PORTFOLIO
TABLE 137. LONZA GROUP: COMPANY SNAPSHOT
TABLE 138. LONZA GROUP: OPERATING SEGMENTS
TABLE 139. LONZA GROUP: PRODUCT PORTFOLIO
TABLE 140. MEDI-CAPS: COMPANY SNAPSHOT
TABLE 141. MEDI-CAPS: PRODUCT PORTFOLIO
TABLE 142. MITSUBISHI CHEMICAL: COMPANY SNAPSHOT
TABLE 143. MITSUBISHI CHEMICAL: OPERATING SEGMENTS
TABLE 144. MITSUBISHI CHEMICAL: PRODUCT PORTFOLIO
TABLE 145. ROXLOR: COMPANY SNAPSHOT
TABLE 146. ROXLOR: PRODUCT SEGMENTS
TABLE 147. ROXLOR: PRODUCT PORTFOLIO
TABLE 148. SNAIL PHARMA INDUSTRY: COMPANY SNAPSHOT
TABLE 149. SNAIL PHARMA INDUSTRY: PRODUCT SEGMENTS
TABLE 150. SNAIL PHARMA INDUSTRY: PRODUCT PORTFOLIO
TABLE 151. SUHEUNG CAPSULE: COMPANY SNAPSHOT
TABLE 152. SUHEUNG CAPSULE: PRODUCT PORTFOLIO
TABLE 153. SUNIL HEALTHCARE: COMPANY SNAPSHOT
TABLE 154. SUNIL HEALTHCARE: OPERATING SEGMENTS
TABLE 155. SUNIL HEALTHCARE: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. SEGMENTATION OF EMPTY CAPSULES MARKET
FIGURE 02. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 03. HIGH BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE THREAT OF SUBSTITUTION
FIGURE 05. MODERATE THREAT OF NEW ENTRANT
FIGURE 06. MODERATE COMPETITIVE RIVALRY
FIGURE 07. TOP INVESTMENT POCKETS, 2017
FIGURE 08. TOP PLAYER POSITIONING, 2017
FIGURE 09. DRIVERS, RESTRAINTS, AND OPPORTUNITIES: GLOBAL EMPTY CAPSULES MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11. HARD GELATIN EMPTY CAPSULES MARKET, 2017-2025 ($MILLION)
FIGURE 12. SOFT GELATIN EMPTY CAPSULES MARKET, 2017-2025 ($MILLION)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PIG MEAT EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BOVINE MEAT EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BONE EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HPMC EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF OTHER RAW MATERIALS EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR CARDIAC THERAPY DRUGS, BY COUNTRY, 2017 & 2025(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. LONZA GROUP: NET SALES, 2015-2017 ($MILLION)
FIGURE 28. LONZA GROUP: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. LONZA GROUP: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. MEDI-CAPS: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. MITSUBISHI CHEMICAL: NET SALES, 20142016 ($MILLION)
FIGURE 32. MITSUBISHI CHEMICAL: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 33. MITSUBISHI CHEMICAL: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. SUNIL HEALTHCARE: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. SUNIL HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. SUNIL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 01. SEGMENTATION OF EMPTY CAPSULES MARKET
FIGURE 02. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 03. HIGH BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE THREAT OF SUBSTITUTION
FIGURE 05. MODERATE THREAT OF NEW ENTRANT
FIGURE 06. MODERATE COMPETITIVE RIVALRY
FIGURE 07. TOP INVESTMENT POCKETS, 2017
FIGURE 08. TOP PLAYER POSITIONING, 2017
FIGURE 09. DRIVERS, RESTRAINTS, AND OPPORTUNITIES: GLOBAL EMPTY CAPSULES MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11. HARD GELATIN EMPTY CAPSULES MARKET, 2017-2025 ($MILLION)
FIGURE 12. SOFT GELATIN EMPTY CAPSULES MARKET, 2017-2025 ($MILLION)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PIG MEAT EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BOVINE MEAT EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BONE EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HPMC EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF OTHER RAW MATERIALS EMPTY CAPSULES MARKET, BY COUNTRY, 2017 & 2025(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR CARDIAC THERAPY DRUGS, BY COUNTRY, 2017 & 2025(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF EMPTY CAPSULES MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. LONZA GROUP: NET SALES, 2015-2017 ($MILLION)
FIGURE 28. LONZA GROUP: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. LONZA GROUP: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. MEDI-CAPS: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. MITSUBISHI CHEMICAL: NET SALES, 20142016 ($MILLION)
FIGURE 32. MITSUBISHI CHEMICAL: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 33. MITSUBISHI CHEMICAL: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 34. SUNIL HEALTHCARE: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. SUNIL HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. SUNIL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
